<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-medicines-04-00047">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deiml</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Haseneder</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zieglgänsberger</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Rammes</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Eisensamer</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Rupprecht</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hapfelmeier</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>α-Thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization</article-title>
  <source>Neuropharmacol.</source>
  <year>2004</year>
  <volume>46</volume>
  <fpage>192</fpage>
  <lpage>201</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2003.09.022</pub-id>
 </element-citation>
</ref>
